It has been shown that the gene amplification of HER2 (ERBB2) and overexpression of EGFR (ERBB1) are respectively associated with aggressive types (papillary serous and clear cell histologies) and a poor survival rate among patients with endometrial cancer [6]. The gene discussed is ERBB2; the disease is endometrial cancer.